Search research articles
Contact Us
Filters
Showing results (261-270 of 267) with videos related to
Page
of 27
Sort By:
You have reached the last page of results.
This site can display upto 267 results.
Cell Death & Disease
|
March 25, 2021
Inhibition of HECT E3 ligases as potential therapy for COVID-19
Giuseppe Novelli, Jing Liu, Michela Biancolella, et al.
Archives of Internal Medicine
|
March 10, 2010
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years
, Rebecca Lodwick, Dominique Costagliola, et al.
Lancet (London, England)
|
November 20, 2022
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series
John P Thornhill, Romain Palich, Jade Ghosn, et al.
JCI Insight
|
January 23, 2026
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death
Olivia Lenoir, Florence Morin, Anouk Walter-Petrich, et al.
Science Translational Medicine
|
August 21, 2020
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations
Ludivine Grzelak, Sarah Temmam, Cyril Planchais, et al.
Eclinicalmedicine
|
March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group
Olivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Science (New York, N.Y.)
|
September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Page
of 27
Search research articles
Search
Showing results (261-270 of 267) with videos related to
Sort By:
Page
of 27
You have reached the last page of results.
This site can display upto 267 results.
Cell Death & Disease
|
March 25, 2021
Inhibition of HECT E3 ligases as potential therapy for COVID-19
Giuseppe Novelli, Jing Liu, Michela Biancolella, et al.
Archives of Internal Medicine
|
March 10, 2010
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years
, Rebecca Lodwick, Dominique Costagliola, et al.
Lancet (London, England)
|
November 20, 2022
Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series
John P Thornhill, Romain Palich, Jade Ghosn, et al.
JCI Insight
|
January 23, 2026
Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death
Olivia Lenoir, Florence Morin, Anouk Walter-Petrich, et al.
Science Translational Medicine
|
August 21, 2020
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations
Ludivine Grzelak, Sarah Temmam, Cyril Planchais, et al.
Eclinicalmedicine
|
March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group
Olivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Science (New York, N.Y.)
|
September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Page
of 27